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Tritrichomonas foetus is a flagellated protozoan parasite that 
colonizes the ileum, cecum, and colon, causing colitis and chro­
nic large bowel diarrhea in cats [1]. Infected cats may have per­
sistent diarrhea as long as 2 years and may remain infected for 
life, although spontaneous resolution of diarrhea may occur 
[2]. In the Republic of Korea, the first clinical case of feline in­
testinal tritrichomoniasis was reported in our previous study 
[3]. We also found that 6.8% (5/73) of surveyed cats in Korea 
were infected with T. foetus (paper submitted). 
To date, the only known effective drug for T. foetus is ronida­
zole [1], which is currently not approved for use in compan­
ion animals [4]. However, the chemical­grade powder is avail­
able and the drug can be formulated into either tablets or cap­
sules by pharmacies [5]. Ronidazole, a 5­nitroimidazole, killed 
T. foetus in vitro [6] and eliminated T. foetus from experimen­
tally infected cats at doses ranging from 30 to 50 mg/kg orally 
twice a day for 14 days [1]. At lower doses (10 mg/kg PO orally 
twice a day for 14 days), ronidazole has been ineffective at elim­
inating T. foetus infection [1]. The purpose of this study was to 
evaluate the efficacy of ronidazole for treatment of cats experi­
mentally infected with a Korean isolate of T. foetus, on the ba­
sis of culture and PCR testing of rectal swab samples. 
T. foetus was originally isolated from a naturally infected fe­
male Siamese cat in our previous study [3]. Trophozoites were 
successfully subcultured in modified Diamond’s medium (Re­
mel, Lenexa, Kansas, USA) in the laboratory and the Korean 
isolate (YG 1) was used for experimental inoculation in this 
study. 
Five to seven month­old female (n=2) and male (n=4) do­
mestic Korean shorthair cats were purchased from a local mar­
ket for experimental infection with T. foetus. Each cat was con­
firmed to be free of T. foetus and Giardia spp. by direct fecal 
smear, rectal swab culture in modified Diamond’s medium, 
and a single­tube nested PCR assay as described previously [7]. 
All cats were additionally examined for the presence of Giar-
dia­specific antigen using commercial Giardia antigen test kit 
(SNAP
TM Giardia, IDEXX Laboratories, Westbrook, Maine, 
USA). 
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Abstract: To evaluate the efficacy of ronidazole for treatment of Tritrichomonas foetus infection, 6 Tritrichomonas-free kit-
tens were experimentally infected with a Korean isolate of T. foetus. The experimental infection was confirmed by direct 
microscopy, culture, and single-tube nested PCR, and all cats demonstrated trophozoites of T. foetus by day 20 post-in-
fection in the feces. From day 30 after the experimentally induced infection, 3 cats were treated with ronidazole (50 mg/kg 
twice a day for 14 days) and 3 other cats received placebo. Feces from each cat were tested for the presence of T. foetus 
by direct smear and culture of rectal swab samples using modified Diamond’s medium once a week for 4 weeks. To con-
firm the culture results, the presence of T. foetus rRNA gene was determined by single-tube nested PCR assay. All 3 cats 
in the treatment group receiving ronidazole showed negative results for T. foetus infection during 2 weeks of treatment and 
4 weeks follow-up by all detection methods used in this study. In contrast, rectal swab samples from cats in the control 
group were positive for T. foetus continuously throughout the study. The present study indicates that ronidazole is also ef-
fective to treat cats infected experimentally with a Korean isolate of T. foetus at a dose of 50 mg/kg twice a day for 14 days. 
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Cats were randomly divided into 2 equal groups; 3 for treat­
ment and 3 for control. Each cat was sedated with aceproma­
zine maleate (0.05 mg/kg, IM), atropine sulfate (0.04 mg/kg, 
SC), and a combination of tiletamine and zolazepam (5 mg/
kg, IM), and received 360 µl of media containing approximate­
ly 2,000,000 live T. foetus trophozoites through a feeding tube. 
Infection with T. foetus was confirmed by direct microscopy 
and single­tube nested PCR testing as described previously [7]. 
After 7 days of oral inoculation, rectal swab samples of each 
cat were suspended in saline and examined microscopically 
daily until motile trophozoites of T. foetus were observed. All 6 
cats demonstrated trophozoites of T. foetus by day 20 post­in­
fection (PI) in the feces. 
From day 30 after the experimentally induced infection, treat­
ment with ronidazole was initiated. Three cats in the treatment 
group were treated with oral administration of ronidazole at 
50 mg/kg twice a day for 14 days, and 3 other cats belonging 
to the control group received empty capsules. Chemical grade 
ronidazole ([1­methyl­5­nitroimidazole­2­yl]­methyl carba­
mate; 99% pure, R7635­5G; Sigma Chemical Co, St. Louis, 
Missouri, USA) was compounded into gel capsules for use in 
this study. Fecal samples from each cat were tested for the pres­
ence of T. foetus trophozoites by direct smear and culture of 
rectal swab samples using modified Diamond’s medium (Re­
mel Media; Remel) once a week for 4 weeks. To confirm the 
culture results, the presence of T. foetus rRNA gene was deter­
mined by single­tube nested PCR assay using a combination 
of TFITS­F/TFITS­R and TFR3/TFR4 primers as described previ­
ously [7].
All cats were confirmed to be free of T. foetus before experi­
mentally induced infection by direct smear and single­tube nest­
ed PCR test of rectal swab samples (data not shown). Some of 
the cats started to reveal T. foetus trophozoites in rectal samples 
at day 7 after inoculation, and all cats were positive by day 20 
PI (Table 1; Fig. 1A). No cat showed signs of diarrhea after ex­
perimentally induced infection in this study.
All 3 cats in the treatment group receiving ronidazole showed 
negative results for T. foetus infection during 2 weeks of treat­
ment and 4 weeks follow­up by all detection methods used in 
this study. In contrast, rectal swab samples from each untreat­
ed cat (control group) were positive for T. foetus continuously 
throughout the study (Table 2; Fig. 1B). 
Currently, there is no effective commercially­available drug 
against intestinal T. foetus infection in cats. Metronidazole has 
often been used as an initial choice of drug against feline in­
testinal trichomoniasis, but organisms were hardly eliminated, 
and diarrhea resumed shortly after the last medication with 
the drug [1]. Ronidazole is reported to be the only known ef­
fective treatment for T. foetus [8]. Oral administration of roni­
dazole at 30­50 mg/kg twice a day for 14 days resolved diar­
rhea and eradicated T. foetus [1]. We therefore evaluated the ef­
Table 1. Confirmation of experimental oral inoculation of cats 
with Tritrichomonas foetus by direct smear examination of rectal 
swab samples
Group Cat ID
Days after inoculation
a
0 7 8 9 10 11 19 20 28
Treatment C-30 - - + + + + + + +
C-45 - - - - - - - + +
C-77 - + + + + + + + +
Control C-16 - - - + + + + +
C-70 - + + + + + + + +
C-71 - - - + + + + + +
aAfter 7 days of the oral infection, rectal swab samples were collected 
and the microscopic examination of the samples suspend  ed in saline 
was performed daily until motile trophozoites of T. foetus were observed. 
Fig. 1. Single-tube nested PCR amplification (208-bp) of Tritrichomonas foetus with primers TFR3/TFR4 and primers TFITS-F/TFITS-
R in cats from Korea on day 0 (A) and day 28 after the initiation of treatment with ronidazole at 50 mg/kg twice a day for 14 days (B). 
Lane 1, molecular weight marker; 2, positive control; 3, culture medium; 4, 5, 6, untreated control cats (C-16, C-70, C-71); 7, 8, 9, 
cats treated with ronidazole (C-30, C-45, C-77).
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ficacy of ronidazole at 50 mg/kg twice a day for 14 days for 
treatment of cats experimentally infected with a Korean isolate 
of T. foetus. 
As has been reported previously [1], cats experimentally in­
fected with a Korean isolate of T. foetus were also successfully 
treated with ronidazole at 50 mg/kg twice a day for 14 days. 
Trophozoites were not detected from cats in the treatment group 
by all detection methods used in this study, including PCR as­
say from 1 week post­treatment, whereas cats belonging the 
control group showed T. foetus­positive continuously through­
out the study period after infection. However, the duration of 
follow­up in the present study was much shorter than that of 
the previous study [1], in which repeated PCR testing was per­
formed over durations of 21­30 weeks to confirm eradication 
of the infection in cats. The authors observed that infection 
could relapse as long as 20 weeks after the treatment, and thus 
short­term studies of drug efficacy in T. foetus infected cats should 
be viewed with caution [1]. 
Unfortunately, we were unable to observe the effects of roni­
dazole treatment on diarrhea in the experimentally infected 
cats, because diarrhea was not observed from any of the 6 cats 
before or during the treatment period. The reason for the ab­
sence of diarrhea in the cats is not known, but this observation 
is consistent with previous studies on experimental infections 
[1,8,9]. Gookin et al. [8] suggested the possibility of strain dif­
ferences in the pathogenicity of T. foetus, as has been reported 
for Trichomonas vaginalis [8,10]. Further studies are needed re­
garding the mechanisms of the pathogenicity of T. foetus in cats.
Another possibility is the difference in susceptibility by breed 
of cats. According to some previous studies, pedigree cats ap­
pear to be more frequently infected with T. foetus than mixed­
bred cats [11,12], although many other researchers did not de­
scribe the same conclusion [12­15]. In our previous study on 
the prevalence of T. foetus in cats in Korea, we found only 1.9% 
(1/53) of non­pedigree domestic cats was positive, while 50% 
(2/4) and 11% (1/9) of Siamese and Persian breeds of cats were 
positive, respectively (paper submitted). However, it is difficult 
to draw conclusions regarding the association between T. foetus 
and breed of cats in the study because of the small number of 
cats surveyed. A high rate of T. foetus infection among specific 
breeds of cats, including Siamese cats, was also reported in a 
previous study in the UK [11]. 
The present study indicates that ronidazole is effective to 
treat cats infected experimentally with a Korean isolate of T. 
foetus at a dose of 50 mg/kg twice a day for 14 days. Although 
no reports are available on the differences in susceptibility by 
different isolates to chemotherapy, the potential presence of 
different strains/isolates and a rather narrow choice of drug to 
treat feline tritrichomoniasis indicate that the susceptibility of 
the Korean isolates of T. foetus to ronidazole needs to be evalu­
ated. 
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